A Clinical and Economic Study of Community-Acquired Pneumonia Between Single Versus Combination Therapy

Author： Hasali Mohamed   Ibrahim Mohamed   Sulaiman Syed   Ahmad Zhari   Hasali Jameela  

Publisher： Springer Publishing Company

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.27, Iss.3, 2005-06, pp. : 249-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Use of Cefuroxime in Paediatric Community-Acquired Pneumonia

By Olivier C.  

Pediatric Drugs, Vol. 2, Iss. 5, 2000-09 ,pp. : 331-343

Adis International

Access to resources Recommend Favorite

Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia: A Meta-Analysis

By Dimopoulos George   Matthaiou Dimitrios K.  

Drugs, Vol. 68, Iss. 13, 2008-01 ,pp. : 1841-1854

Adis International

Access to resources Recommend Favorite

Tigecycline: In Community-Acquired Pneumonia

By McKeage Kate   Keating Gillian M.  

Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. : 2633-2644

Adis International

Access to resources Recommend Favorite

Community‐Acquired Pneumonia

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 3, 2004-09 ,pp. : 212-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimal Pharmacological Therapy for Community-Acquired Pneumonia: The Role of Dual Antibacterial Therapy

By Epstein Benjamin J.   Gums John G.  

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 1949-1971

Adis International

Access to resources Recommend Favorite